Does TREAT Give the Boot to ESAs in the Treatment of CKD Anemia?
Author:
- Ajay K. SinghASAjay K. Singh
- 1 January 2010
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 21 (1) , 2-6
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Anemia Management and Association of Race With Mortality and Hospitalization in a Large Not-for-Profit Dialysis OrganizationAmerican Journal of Kidney Diseases, 2009
- ResolvedJournal of the American Society of Nephrology, 2009
- Critiques of Clinical Guidelines in Nephrology: AnaemiaNephron Clinical Practice, 2008
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomesKidney International, 2008
- From Anemia Trials to Clinical Practice: Understanding the Risks and Benefits When Setting Goals for TherapySeminars in Dialysis, 2008
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated AnemiaJAMA, 2008
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Epoetin requirements predict mortality in hemodialysis patientsAmerican Journal of Kidney Diseases, 2004
- Epoetin alpha and beta in their erythropoetin isoform compositions and biological propertiesBritish Journal of Haematology, 1998
- S7.7 The role of carbohydrate on the biological activity of erythropoietinGlycoconjugate Journal, 1993